Skip to content

Platelet-Rich Plasma (PRP) in Reconstructive Surgery on Children With Retractable Burn Sequelae on Extremities

PRP on Children With Retractable Burn Sequelae Who Have Submitted Release of Burn Contractures and Skin Graft on Their Limbs. A Double-Blind Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00858442
Enrollment
44
Registered
2009-03-09
Start date
2009-03-31
Completion date
2012-11-30
Last updated
2015-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Keywords

Burn sequelae, PRP, Children

Brief summary

Does the addition of Platelet-Rich Plasma (PRP) to release of burn contractures and skin graft on the limbs of children with retractable burn sequelae reduce the initial time of the compressive treatment and maintain or lower the graft's retraction?

Detailed description

Hypothesis: 1. The use of PRP will allow to initiate sooner the compressive treatment during the post graft surgery evolution, in fewer days on average than the traditional method (18 ds). 2. The use of PRP will maintain the same initial size of the graft. The study's domain corresponds to burn sequelae on children in treatment with reconstructive surgery due to retractile sequelae located on their upper and lower limbs, with functional compromise during their growth process. One of the treatments used for this problem is the surgical technique of with release of burn contractures and skin graft. Split skin grafts are at risk of suboptimal take due to bleeding and infection which would, on the one hand, delay the initiation of the rehabilitation with preventive compression to avoid the retraction of the grafted area. 20% of the children that arrive in COANIQUEM (approximately 7,000 annually), require rehabilitation. Of these, 32% have surgery and 9% of those are release of burn contractures and skin graft mainly on extremities.

Interventions

PROCEDUREWith PRP

Release of burn contractures and skin graft on the affected limb, a rigorous haemostasis. The surgeon must distribute the activated PRP evenly, forming a very fine clot over it. Immediately the split skin graft must be applied, duly fenestrated. The grafted zone will be measured in it's longest width and length, taking a standardized photograph. On the 5th day the nurse will evaluate the graft's conditions. The evaluation will be done following a previously established follow-up protocol. Measurements of width & length of graft and standardized photo taken at the initiation of the compressive system. Measurement of graft's width & length and standardized photo at the end of the compressive system according protocol. Statistical analysis.

Sponsors

Zimmer Biomet
CollaboratorINDUSTRY
Corporation for the Aid of Burned Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Patients with burn sequelae on their upper or lower limbs * Treated with release of burn contractures and skin graft on their upper or lower limbs * Between 5 and 21 years old * Following instructions in their homes * With informed and written consent * Weight 35 Kg or more * Blood count * Hepatic and coagulation tests * Paediatric evaluation prior to surgery

Exclusion criteria

* Background of blood alterations * Another current pathology

Design outcomes

Primary

MeasureTime frameDescription
Median Time Between Surgery Date and Start Date Compression.dayParticipants were followed from the date of surgery and the date of onset of compression for a minimum of 13.5 days and a maximum of 27 days

Secondary

MeasureTime frameDescription
Width of the Graftstart and end compressionCentral width measurement graft between the start and the end of the compression
Length of the Graftstart and end compressionCentral length measurement graft between the start and the end of the compression

Countries

Chile

Participant flow

Recruitment details

Participants were recruited on the day of the scheduled surgery. The researcher checked the inclusion criteria. Explained to the parents and patient surgical procedure, risk of complications and are invited to participate voluntarily in the study. Informed consent is signed. They recruited 44 children in total between April 6,2009 and August 9,2011

Pre-assignment details

Potential candidates to enter the study were 80. Of these, 20 were excluded for having a weight less than 35 kg; 15 for failing to ensure their attendance at the controls and 1 have coagulation disorders

Participants by arm

ArmCount
Without PRP
Patients with burns sequelae on their limbs treated with release of burns contractures and skin graft between 2008-2010.
21
With PRP
Patients with burns sequelae on their limbs treated with release of burn contractures and skin graft with PRP between 2008-2010.
23
Total44

Withdrawals & dropouts

PeriodReasonFG000FG001
Compression:Start to FinishLost to Follow-up13

Baseline characteristics

CharacteristicWithout PRPWith PRPTotal
Age, Continuous14.5 years
STANDARD_DEVIATION 3.1
14.1 years
STANDARD_DEVIATION 3.5
14.2 years
STANDARD_DEVIATION 3.3
Region of Enrollment
Chile
21 participants23 participants44 participants
Sex: Female, Male
Female
8 Participants17 Participants25 Participants
Sex: Female, Male
Male
13 Participants6 Participants19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 210 / 23
serious
Total, serious adverse events
1 / 211 / 23

Outcome results

Primary

Median Time Between Surgery Date and Start Date Compression.

Participants were followed from the date of surgery and the date of onset of compression for a minimum of 13.5 days and a maximum of 27 days

Time frame: day

Population: A participant may have one, two or three areas grafted

ArmMeasureValue (MEDIAN)
Without PRPMedian Time Between Surgery Date and Start Date Compression.17 day
With PRPMedian Time Between Surgery Date and Start Date Compression.19 day
p-value: >0.157495% CI: [-7.332, 2.428]t-test, 1 sided
Secondary

Length of the Graft

Central length measurement graft between the start and the end of the compression

Time frame: start and end compression

ArmMeasureValue (MEDIAN)
Without PRPLength of the Graft0.2 centimeter
With PRPLength of the Graft0.2 centimeter
p-value: >0.398Wilcoxon (Mann-Whitney)
Secondary

Width of the Graft

Central width measurement graft between the start and the end of the compression

Time frame: start and end compression

ArmMeasureValue (MEDIAN)
Without PRPWidth of the Graft0.1 centimeter
With PRPWidth of the Graft0.3 centimeter
p-value: >0.59395% CI: [-1.28561, 0.74189]t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026